Rozalina Mccoy is an Endocrinologist in Baltimore, Maryland. Dr. Mccoy has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Diabetic Hyperglycemic Hyperosmolar Syndrome.

Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Maturity Onset Diabetes of the Young, and Pancreaticoduodenectomy.

Zhanna Kalikhman is a primary care provider, practicing in Internal Medicine in Elkridge, Maryland. Dr. Kalikhman is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 1 Diabetes (T1D), Diabetic Neuropathy, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Nisha Abraham is an Endocrinologist in Hanover, Maryland. Dr. Abraham is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Thyroid Nodule, Diabetic Neuropathy, and Diabetic Nephropathy.

Rubina Alvi is a primary care provider, practicing in Geriatrics in Elkridge, Maryland. Dr. Alvi is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are High Cholesterol, Vitamin D Deficiency, Generalized Anxiety Disorder (GAD), and Familial Hypertension.

Michele Henley is a primary care provider, practicing in Family Medicine in Baltimore,, Maryland. Dr. Henley is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Bronchitis, Vulvovaginitis, Acute Cystitis, and Syphilis.

Saba Sheikh is a primary care provider, practicing in Internal Medicine in Columbia, Maryland. Dr. Sheikh is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Familial Hypertension, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Meegan Chestnut is a primary care provider, practicing in Internal Medicine in Glen Burnie, Maryland. Dr. Chestnut is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Obesity, High Cholesterol, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension.

Kashif Munir is an Endocrinologist in Baltimore, Maryland. Dr. Munir is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.

Jonathan Rich is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Rich is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Heart Failure, Hypertension, Type 2 Diabetes (T2D), Heart Transplant, and Lung Transplant.

Nicholas Argento, M.D. attended Georgetown University and graduated Magna Cum Laude with a BS in Biology, then the University of Maryland School of Medicine and graduated Cum Laude. He completed his residency in Internal Medicine and fellowship in Diabetes, Endocrine and Metabolism at the University of Maryland Medical System. He joined Maryland Endocrine full time in 1991. He has been the Medical Advisor to the diabetes program at Johns Hopkins Howard County Medical Center since 1995, and gives talks regularly to medical and patient audiences on diabetes. He has a strong interest in type 1 diabetes (T1D), and has extensive experience in utilizing insulin pumps and continuous glucose monitoring (CGM) to help patients safely achieve better blood glucose control. He has 4 publications in medical journals on different aspects of CGM use, and was co-author or contributor to multiple chapters in the 2013 American Diabetes Association book, Putting Your Patient On The Pump, 2nd edition. He has presented clinical research multiple times at the American Diabetes Association Scientific Sessions and other medical meetings, and has spoken to local, national, and international audiences on insulin pumps and the clinical application of CGM technology. He is very active on and lends medical support to and has written numerous articles for the T1DExchange website myglu.org, a website dedicated to outreach, research and engagement of and for the T1D community. For more information, visit marylandendocrine.com. Dr. Argento is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 1 Diabetes (T1D), Hypothyroidism, Type 2 Diabetes (T2D), and Vitamin D Deficiency.

Heidi Karon is an Endocrinologist in Columbia, Maryland. Dr. Karon is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Hypothyroidism, Thyroid Storm, Hyperthyroidism, and Type 1 Diabetes (T1D).

Dr. Rita Kalyani is a Professor of Medicine at Johns Hopkins School of Medicine. She graduated with an undergraduate degree from Harvard College and completed her medical degree, residency, and fellowship at Johns Hopkins. She also obtained a Masters in Health Science degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. As a NIH-funded clinician scientist, Dr. Kalyani has authored over 175 peer-reviewed publications and built a research program focused on understanding the factors leading to development of diabetes complications, particularly in high-risk populations. She has conducted epidemiological and patient-oriented research that has led to fundamental discoveries regarding the development of skeletal muscle loss, physical disability, and frailty in diabetes. She has also spearheaded studies investigating sex differences in cardiovascular disease and diabetes which have influenced primary prevention guidelines. Dr. Kalyani launched the Diabetes Management Service for Johns Hopkins’ Total Pancreatectomy Islet Auto Transplant Program in 2011. She is the co-founder of the Johns Hopkins Diabetes POC-IT Guide for healthcare professionals. She is also the founder and past Editor-in-Chief of the Johns Hopkins Patient Website to Diabetes. Dr. Kalyani has been the Chief Scientific and Medical Officer of the American Diabetes Association since 2025. She previously served as President of Medicine & Science on the ADA's National Board of Directors. She continues to have a clinical practice as an adult endocrinologist. Dr. Kalyani is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Seasonal Affective Disorder (SAD), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Pancreatectomy, and Islet Cell Transplantation.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Sheela N. Magge, M.D., M.S.C.E., is a pediatric endocrinologist and the director of the Division of Pediatric Endocrinology, as well as the Lawson Wilkins Endowed Chair of Pediatric Endocrinology at Johns Hopkins Children’s Center. Dr. Magge’s expertise includes the diagnosis and treatment of endocrine disorders in children and adolescents. Primary related conditions that she treats include type 2 diabetes mellitus, pre-diabetes, obesity, congenital insulin resistance syndromes, congenital lipodystrophy and polycystic ovary syndrome. Dr. Magge is an active member of the National Pediatric Endocrine Society. She is also a standing member of the National Institutes of Health (NIH) Human Studies of Diabetes and Obesity Study Section. A professor of pediatrics, Dr. Magge obtained a master’s degree in clinical epidemiology from the University of Pennsylvania. Dr. Magge is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Obesity, Type 2 Diabetes (T2D), Congenital Hyperinsulinism, and Maturity Onset Diabetes of the Young.

Dr. Jodi Segal is a professor of medicine at the Johns Hopkins University School of Medicine. She has joint appointments in health policy and management, and epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Segal is internationally recognized as a clinician-investigator in comparative effectiveness research and pharmacoepidemiology. She trains investigators to conduct research to advance Johns Hopkins Medicine as a learning health system. She serves as the associate director of the Center for Health Services and Outcomes Research (CHSOR) and the co-director of the Center for Drug Safety and Effectiveness (CDSE), both in the School of Public Health. Dr. Segal received a B.S. from The Pennsylvania State University. She earned her M.D. from the University of Pittsburgh School of Medicine and her M.P.H. from the Johns Hopkins Bloomberg School of Public Health. She completed her residency at the University of Chicago and a fellowship in general nternal medicine at Johns Hopkins. She is a member of Phi Beta Kappa and Alpha Omega Alpha. Dr. Segal is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Giant Papillary Conjunctivitis, Type 2 Diabetes (T2D), Vernal Keratoconjunctivitis, and Allergic Conjunctivitis.

Todd T. Brown, MD, PhD is a clinical investigator who focuses on body composition, metabolic, and skeletal abnormalities observed in people with HIV, particularly as related to aging. Through translational investigation, epidemiologic studies, and clinical trials, he has been interested in understanding the pathogenesis of glucose disorders, fat changes, hormonal dysregulation, and osteoporosis in people with HIV, the consequences of these conditions (eg cardiovascular disease, frailty), and their optimal evaluation and management. Dr. Brown is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Low Blood Sugar, Osteoporosis, Malnutrition, Gastric Bypass, and Gastrostomy.

Amal Hassan Ahmed Awadalla, M.D., practices internal medicine at Johns Hopkins Community Physicians East Baltimore Medical Center. She received her medical degree from Faculty of Medicine University of Khartoum, and completed her residency at Queens Hospital Center. Dr. Awadalla is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Neurosarcoidosis, and Sarcoidosis.

Tara Hebert, M.D., practices internal medicine at Johns Hopkins Community Physicians East Baltimore Medical Center. She received her medical degree from Johns Hopkins University School of Medicine, and also completed her residency in internal medicine at Johns Hopkins Medicine School of Medicine. Dr. Hebert is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Maturity Onset Diabetes of the Young, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Justin Tcheugui is an Endocrinologist in Baltimore, Maryland. Dr. Tcheugui is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Gestational Diabetes.